Members of the DQSA Coalition and 39 State Pharmacy Associations Show Strong Support for Bipartisan Legislation, HR 2871, The Preserving Patient Access to Compounded Medications Act.

The  DQSA Coalition , a broad cross-section of organizations representing varied healthcare providers, state pharmacy associations, pharmacists and patients, sent a letter of support today to  U.S. Representatives Morgan Griffith (VA) and
Henry Cuellar (TX), Sponsors of  HR 2871, The Preserving Patient Access to Compounded Medications Act.

From the letter - "The undersigned organizations represent patient advocates, physicians, pharmacists and other healthcare providers who are united in a mission to preserve patient safety and patient access to compounded medications. Since 2014, our organizations have been meeting and working together as part of a coalition ("the DQSA Coalition") to provide input to the FDA, to State Boards of Pharmacy and to the Congress about our concerns with FDA's implementation and enforcement of the Drug Quality and Security Act of 2013 ("DQSA", P.L. 113-54) and to seek solutions and policies that better balance patient safety with access to compounded medications.

"The DQSA Coalition strongly supports H.R. 2871, The Preserving Patient Access to Compounded Medications Act, and we urge the Congress to pass this important legislation as soon as possible. H.R. 2871 will clarify key provisions of the Food, Drug and Cosmetic Act (FDCA) as amended by the DQSA that the FDA has been misinterpreting in a way that has jeopardized access to compounded medications for the patients that need them."

IACP Members: Please Ask Your Representatives to Support HR 2871!

Take Action, Today!

Please Click Here to send a direct communication to your Representative. 
It will only take a few minutes with our easy-to-use Voter Voice action alert platform. 

This important bill will help protect access to compounded medications upon which your patients rely. It will help clarify the Drug Quality & Security Act (DQSA) in a way that will better align the statute with congressional intent and better balance public safety and patient access.

About the DQSA Coalition:

IACP was instrumental in creating the DQSA Coalition and has led this broad provider and pharmacy organization with a primary goal of ensuring the FDA implements the Drug Quality & Security Act as Congress fully intended.

IACP is Working to Protect, Promote & Advance Pharmacy Compounding.

Please email questions to IACP at [email protected].
STAY CONNECTED: